Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
St. John's Health System |
---|---|
Information provided by: | St. John's Health System |
ClinicalTrials.gov Identifier: | NCT00713674 |
The purpose of this study is to examine treatment method of Methicillin-resistant Staphylococcus aureus (MRSA) decolonization in patients.
Condition | Intervention |
---|---|
Methicillin-Resistant Staphylococcus Aureus |
Other: Theraworx Drug: mupirocin antibiotic ointment |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind (Subject), Parallel Assignment, Safety/Efficacy Study |
Official Title: | Comparison of Decolonization of MRSA Using Theraworx |
Estimated Enrollment: | 60 |
Study Start Date: | March 2008 |
Estimated Study Completion Date: | March 2009 |
Estimated Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: No Intervention
No Treatment
|
|
2: Experimental
Theraworx intranasal
|
Other: Theraworx
Theraworx swab intranasal BID for 5 days
|
3: Active Comparator
mupirocin antibiotic ointment intranasal
|
Drug: mupirocin antibiotic ointment
mupirocin antibiotic ointment swab intranasal BID for 5 days
|
Decolonization therapy is indicated for management of patients with MRSA. Theraworx is reported to be an effective antimicrobial against multiple organisms. In this study, patients with positive MRSA colonization culture will be treated with Theraworx to evaluate decolonization duration capability.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Roger E Huckfeldt, MD | 417-820-3185 | roger.huckfeldt@mercy.net |
United States, Missouri | |
St John's Hospital-Medical Research Institute | Recruiting |
Springfield, Missouri, United States, 65804 | |
Principal Investigator: Roger E Huckfeldt, MD |
Principal Investigator: | Roger E Huckfeldt, MD | St. Johns' Health System-Medical Research Institute |
Responsible Party: | St. John's Medical Research Institute ( Roger Huckfeldt, MD ) |
Study ID Numbers: | SJMRSA-01 |
Study First Received: | July 7, 2008 |
Last Updated: | July 10, 2008 |
ClinicalTrials.gov Identifier: | NCT00713674 |
Health Authority: | United States: Institutional Review Board |
Methicillin resistance |
Bacterial Infections Staphylococcal Infections Gram-Positive Bacterial Infections Mupirocin Methicillin |
Anti-Infective Agents Anti-Bacterial Agents Protein Synthesis Inhibitors Molecular Mechanisms of Pharmacological Action |
Therapeutic Uses Enzyme Inhibitors Pharmacologic Actions |